Advanced Cancer Clinical Trials in Aurora, Colorado

4 studies are recruiting for advanced cancer in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. ALIGN for Older Adults With Cancer in SNFs

    The goal of this clinical trial is to learn if it is possible to deliver a palliative care intervention called ALIGN (Assessing and Listening to Individual Goals and Needs) to hospitalized older adults with advanced cancer who are discharged to a skilled nursing facility and their caregivers. The m…

    Stage
    Not phased
    Ages
    18 to 98
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT06616298 on ClinicalTrials.gov

  2. A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

    This study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. reference regimens. Currently study will only be enrolling the Phase 1b and the Phase 2a protocol requirements will be added to the study nea…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado Cancer Center, Aurora, Colorado
    Locations
    5 in total
    Run by
    7 Hills Pharma, LLC

    See if you can join NCT06362369 on ClinicalTrials.gov

  3. Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

    This is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with advanced or metastatic solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UCHealth Cancer Care - Anschutz Medical Campus, Aurora, Colorado
    Locations
    21 in total
    Run by
    I-Mab Biopharma US Limited

    See if you can join NCT04900818 on ClinicalTrials.gov

  4. Psilocybin Therapy in Advanced Cancer

    The purpose of this research is to study the safety and effects of single-dose psilocybin 25mg versus an active placebo (single dose niacin 100mg) in the treatment of anxiety, depression, and existential distress (i.e., loss of meaning and hope; fear of death) in advanced cancer (i.e., stage 3 or 4…

    Stage
    Phase 2
    Ages
    21 to 100
    Site
    University of Colorado Anschutz Medical campus (CU AMC), Aurora, Colorado
    Locations
    2 in total
    Run by
    NYU Langone Health

    See if you can join NCT05398484 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.